Laura J Vella
Cited by
Cited by
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the …
C Théry, KW Witwer, E Aikawa, MJ Alcaraz, JD Anderson, ...
Journal of extracellular vesicles 7 (1), 1535750, 2018
Packaging of prions into exosomes is associated with a novel pathway of PrP processing
LJ Vella, RA Sharples, VA Lawson, CL Masters, R Cappai, AF Hill
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2007
EVpedia: a community web portal for extracellular vesicles research
DK Kim, J Lee, SR Kim, DS Choi, YJ Yoon, JH Kim, G Go, D Nhung, ...
Bioinformatics 31 (6), 933-939, 2015
Inhibition of γ‐secretase causes increased secretion of amyloid precursor protein C‐terminal fragments in association with exosomes
RA Sharples, LJ Vella, RM Nisbet, R Naylor, K Perez, KJ Barnham, ...
The FASEB Journal 22 (5), 1469-1478, 2008
The role of exosomes in the processing of proteins associated with neurodegenerative diseases
LJ Vella, RA Sharples, RM Nisbet, R Cappai, AF Hill
European Biophysics Journal 37, 323-332, 2008
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
JA Welsh, DCI Goberdhan, L O'Driscoll, EI Buzas, C Blenkiron, ...
Journal of extracellular vesicles 13 (2), e12404, 2024
Enrichment of prion protein in exosomes derived from ovine cerebral spinal fluid
LJ Vella, DLV Greenwood, R Cappai, JPY Scheerlinck, AF Hill
Veterinary immunology and immunopathology 124 (3-4), 385-393, 2008
A rigorous method to enrich for exosomes from brain tissue
LJ Vella, BJ Scicluna, L Cheng, EG Bawden, CL Masters, CS Ang, ...
Journal of extracellular vesicles 6 (1), 1348885, 2017
Focus on extracellular vesicles: exosomes and their role in protein trafficking and biomarker potential in Alzheimer’s and Parkinson’s disease
LJ Vella, AF Hill, L Cheng
International journal of molecular sciences 17 (2), 173, 2016
MEK inhibition, alone or in combination with BRAF inhibition, affects multiple functions of isolated normal human lymphocytes and dendritic cells
LJ Vella, A Pasam, N Dimopoulos, M Andrews, A Knights, AL Puaux, ...
Cancer immunology research 2 (4), 351-360, 2014
C-Jun N-terminal kinase controls TDP-43 accumulation in stress granules induced by oxidative stress
J Meyerowitz, SJ Parker, LJ Vella, DCH Ng, KA Price, JR Liddell, ...
Molecular neurodegeneration 6, 1-22, 2011
The emerging role of exosomes in epithelial–mesenchymal-transition in cancer
LJ Vella
Frontiers in oncology 4, 361, 2014
Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma
A Jayachandran, M Anaka, P Prithviraj, C Hudson, SJ McKeown, PH Lo, ...
Oncotarget 5 (14), 5782, 2014
The contribution of tumour-derived exosomes to the hallmarks of cancer
K Meehan, LJ Vella
Critical reviews in clinical laboratory sciences 53 (2), 121-131, 2016
Influence of species and processing parameters on recovery and content of brain tissue-derived extracellular vesicles
Y Huang, L Cheng, A Turchinovich, V Mahairaki, JC Troncoso, ...
Journal of extracellular vesicles 9 (1), 1785746, 2020
Characterization of brain‐derived extracellular vesicle lipids in Alzheimer's disease
H Su, YH Rustam, CL Masters, E Makalic, CA McLean, AF Hill, ...
Journal of extracellular vesicles 10 (7), e12089, 2021
Mouse-adapted sporadic human Creutzfeldt–Jakob disease prions propagate in cell culture
VA Lawson, LJ Vella, JD Stewart, RA Sharples, H Klemm, DM Machalek, ...
The international journal of biochemistry & cell biology 40 (12), 2793-2801, 2008
Small RNA fingerprinting of Alzheimer’s disease frontal cortex extracellular vesicles and their comparison with peripheral extracellular vesicles
L Cheng, LJ Vella, KJ Barnham, C McLean, CL Masters, AF Hill
Journal of extracellular vesicles 9 (1), 1766822, 2020
Intercellular resistance to BRAF inhibition can be mediated by extracellular vesicle–associated PDGFRβ
LJ Vella, A Behren, B Coleman, DW Greening, AF Hill, J Cebon
Neoplasia 19 (11), 932-940, 2017
BRAF Inhibitor–Driven Tumor Proliferation in a KRAS-Mutated Colon Carcinoma Is Not Overcome by MEK1/2 Inhibition
MC Andrews, A Behren, F Chionh, J Mariadason, LJ Vella, H Do, ...
Journal of Clinical Oncology 31 (35), e448-e451, 2013
The system can't perform the operation now. Try again later.
Articles 1–20